EZH2 deletion promotes spermatogonial differentiation and apoptosis

被引:32
|
作者
Jin, Cheng [1 ,2 ]
Zhang, Yan [1 ,3 ]
Wang, Zhi-Peng [1 ,2 ]
Wang, Xiu-Xia [1 ]
Sun, Tie-Cheng [1 ,2 ]
Li, Xiao-Yu [1 ,2 ]
Tang, Xin [1 ,2 ]
Cheng, Jin-Mei [1 ,2 ]
Li, Jian [1 ,2 ]
Chen, Su-Ren [1 ]
Deng, Shou-Long [1 ]
Liu, Yi-Xun [1 ]
机构
[1] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China
[2] Univ Chinese Acad Sci, Beijing, Peoples R China
[3] Changsha Reprod Med Hosp, Changsha, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
STEM-CELL COMPARTMENTS; GERMLINE TRANSMISSION; DOWN-REGULATION; RETINOIC ACID; VITAMIN-A; PROLIFERATION; EXPRESSION; SPERMATOGENESIS; IDENTIFICATION; MAINTENANCE;
D O I
10.1530/REP-17-0302
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Spermatogenesis is crucial for male fertility and is therefore tightly controlled by a variety of epigenetic regulators. However, the function of enhancer of zeste homolog 2 (EZH2) in spermatogenesis and the molecular mechanisms underlying its activity remain poorly defined. Here, we demonstrate that deleting EZH2 promoted spermatogonial differentiation and apoptosis. EZH2 is expressed in spermatogonia, spermatocytes and round and elongated spermatids from stage 9 to 11 but not in leptotene and zygotene spermatocytes. Knocking down Ezh2 in vitro using a lentivirus impaired self-renewal in spermatogonial stem cells (SSCs), and the conditional knockout of Ezh2 in spermatogonial progenitors promoted precocious spermatogonial differentiation. EZH2 functions to balance self-renewal and differentiation in spermatogonia by suppressing NEUROG3 and KIT via a direct interaction that is independent of its histone methyltransferase activity. Moreover, deleting Ezh2 enhanced the activation of CASP3 in spermatids, resulting in reduced spermatozoa production. Collectively, these data demonstrate that EZH2 plays a nonclassical role in the regulation of spermatogonial differentiation and apoptosis in murine spermatogenesis.
引用
收藏
页码:615 / 625
页数:11
相关论文
共 50 条
  • [1] Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells
    O'Brien, Eleanor
    Tse, Carmen
    Tracy, Ian
    Reddin, Ian
    Selfe, Joanna
    Gibson, Jane
    Tapper, William
    Pengelly, Reuben J.
    Gao, Jinhui
    Aladowicz, Ewa
    Petts, Gemma
    Thway, Khin
    Popov, Sergey
    Kelsey, Anna
    Underwood, Timothy J.
    Shipley, Janet
    Walters, Zoe S.
    CLINICAL EPIGENETICS, 2023, 15 (01)
  • [2] Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells
    Eleanor O’Brien
    Carmen Tse
    Ian Tracy
    Ian Reddin
    Joanna Selfe
    Jane Gibson
    William Tapper
    Reuben J. Pengelly
    Jinhui Gao
    Ewa Aladowicz
    Gemma Petts
    Khin Thway
    Sergey Popov
    Anna Kelsey
    Timothy J. Underwood
    Janet Shipley
    Zoë S. Walters
    Clinical Epigenetics, 15
  • [3] Wedelolactone Promotes the Chondrogenic Differentiation of Mesenchymal Stem Cells by Suppressing EZH2
    Qin, Wei
    Yang, Lin
    Chen, Xiaotong
    Ye, Shanyu
    Liu, Aijun
    Chen, Dongfeng
    Hu, Kunhua
    INTERNATIONAL JOURNAL OF STEM CELLS, 2023, 16 (03) : 326 - 341
  • [4] FLT3 Inhibition Downregulates EZH2 in AML and Promotes Myeloid Differentiation
    Sung, Pamela J.
    Sidoli, Simone
    Riedel, Simone S.
    Kulej, Katarzyna
    Xie, Hongbo
    Manning, Bryan
    Tsai, Daniel
    Wertheim, Gerald
    Garcia, Benjamin A.
    Meyer, Sara E.
    Bernt, Kathrin M.
    Carroll, Martin P.
    BLOOD, 2021, 138
  • [5] Dual role of EZH2 in megakaryocyte differentiation
    Mazzi, Stefania
    Dessen, Philippe
    Vieira, Mathieu
    Dufour, Virginie
    Cambot, Marie
    El Khoury, Mira
    Antony-Debre, Ileana
    Arkoun, Brahim
    Basso-Valentina, Francesca
    BenAbdoulahab, Salwa
    Edmond, Valerie
    Rameau, Philippe
    Petermann, Rachel
    Wittner, Monika
    Cassinat, Bruno
    Plo, Isabelle
    Debili, Najet
    Raslova, Hana
    Vainchenker, William
    BLOOD, 2021, 138 (17) : 1603 - 1614
  • [6] EZH2 promotes breast cancer bone metastasis
    Qu, Jingkun
    Zhang, Lin
    Zhou, Zhifen
    Yu, Dihua
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Regulation of T Cell Differentiation and Function by EZH2
    Karantanos, Theodoros
    Chistofides, Anthos
    Barhdan, Kankana
    Li, Lequn
    Boussiotis, Vassiliki A.
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [8] EZH2: a pivotal regulator in controlling cell differentiation
    Chen, Ya-Huey
    Hung, Mien-Chie
    Li, Long-Yuan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2012, 4 (04): : 364 - 375
  • [9] Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis
    Nakagawa, Shigeki
    Okabe, Hirohisa
    Sakamoto, Yasuo
    Hayashi, Hiromitsu
    Hashimoto, Daisuke
    Yokoyama, Naomi
    Sakamoto, Keita
    Kuroki, Hideyuki
    Mima, Kosuke
    Nitta, Hidetoshi
    Imai, Katsunori
    Chikamoto, Akira
    Watanabe, Masayuki
    Beppu, Toru
    Baba, Hideo
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S667 - S675
  • [10] Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis
    Shigeki Nakagawa
    Hirohisa Okabe
    Yasuo Sakamoto
    Hiromitsu Hayashi
    Daisuke Hashimoto
    Naomi Yokoyama
    Keita Sakamoto
    Hideyuki Kuroki
    Kosuke Mima
    Hidetoshi Nitta
    Katsunori Imai
    Akira Chikamoto
    Masayuki Watanabe
    Toru Beppu
    Hideo Baba
    Annals of Surgical Oncology, 2013, 20 : 667 - 675